Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
Schlingemann
R O
RO
Department of Clinical Ophthalmology, Moorfields Eye Hospital, London.
van Hinsbergh
V W
VW
D016228:Endothelial Growth Factors / Q000502:physiology*; D005123:Eye / Q000098:blood supply*; D005128:Eye Diseases / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D000860:Hypoxia / Q000378:metabolism; D007511:Ischemia / Q000378:metabolism; D008222:Lymphokines / Q000502:physiology*; D009389:Neovascularization, Pathologic / Q000378:metabolism; D018919:Neovascularization, Physiologic; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology; D017978:Receptors, Growth Factor / Q000502:physiology; D040262:Receptors, Vascular Endothelial Growth Factor; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D017978:Receptors, Growth Factor; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D020794:Receptor Protein-Tyrosine Kinases; D040262:Receptors, Vascular Endothelial Growth Factor